With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.

During a live event, Bruna Pellini, MD, discussed the efficacy of cemiplimab in PD-L1-high non–small cell lung cancer.

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

The diagnosis of a suspected lung, head, and neck cancer called NUT carcinoma should include additional testing capable of detecting gene fusions that are definitive markers of the disease, according ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly ...

Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors ...

Dr. Kara Leigh Roncin will be honored at the International Association of Top Professionals (IAOTP) annual awards gala in Las Vega ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...